Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: Follow-up at 52 weeks

Digestion

Volumn 65, Issue 1, 2002, Pages 35-40

  Fontana, M G ^a   Moneghini, D ^a   Villanacci, V ^a   Donato, F ^a   Rindi, G ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Aberrant crypt foci; Cholecystokinin B gastrin receptor; Cholecystokinin B gastrin receptor antagonist (CR2945); Colorectal cancer; Gastrin

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; GASTRIN; GASTRIN RECEPTOR; ITRIGLUMIDE; SODIUM CHLORIDE; BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; FOLLOW UP; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECTUM; ADENOCARCINOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DRUG ANTAGONISM; MOUSE STRAIN; TIME;

ADENOCARCINOMA; ANIMAL; BENZODIAZEPINES; COLONIC NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; RECEPTORS, CHOLECYSTOKININ; TIME FACTORS; ANIMALS; RECEPTOR, CHOLECYSTOKININ B;

EID: 0036010669     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051929     Document Type: Article

References (43)

1. Experimental colon cancer
2. Aberrant crypts: Potential preneoplastic lesions in the murine colon
3. Aberrant crypts: Putative preneoplastic foci in human colonic mucosa
4. Identification and quantification of aberrant crypt foci and micro adenomas in the human colon
5. Aberrant crypt foci in patients with colorectal cancer
6. Aberrant crypt foci of the colon as precursor of adenoma and cancer
7. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease
8. The identification of the monoclonality in human aberrant crypt foci
9. Aberrant crypt foci in the human colon
10. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings
11. Dose response and proliferative characteristics of aberrant crypts foci: Putative preneoplastic lesions in rat colon
12. Mucosal DNA synthesis: A short term index of the trophic action of gastrin
13. New aspect of the trophic action of gastrointestinal hormones
14. Growth of pancreas and gastrointestinal mucosa by secretin, cerulein and pentagastrin
15. Gastrin receptors in human colonic carcinoma
16. Growth factors and intestinal neoplasm
17. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin
18. Gastrin receptor in normal and malignant gastrointestinal mucosa: Age associated changes
19. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice
20. Inhibition of pentagastrin stimulated upregulation of gastrin receptor and growth in mouse colon tumour in vivo by proglumide, a gastrin receptor antagonist
21. Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells
22. Gastrin has no promoting effect on chemically induced colonic tumors in Wistar rats
23. Prolonged hypergas-trinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome
24. Plasma gastrin concentration are normal in patients with colorectal neoplasia and unaltered following tumor resection
25. Inhibitory effect of a gastrin receptor antagonist, CR 2945, on 1,2-dimethylhydrazine-induced colorectal cancer in mice
26. CCKb/gastrin receptor antagonists as potential drugs for peptic ulcer therapy
27. Use of avidin-biotin-peroxidase complex (ABC) in immunoper-oxidase technique
28. Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis
29. Evidence for autocrine growth stimulation of cultured colon tumor cells by gastrin/cholecystokinin-like peptide
30. The 78 kDa gastrin-binding protein is a candidate receptor for autocrine progastrin
31. Gastrin receptor gene expression in several human carcinomas
32. Expression of gastrin, gastrin CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas
33. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumours
34. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblast. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors
35. Glycine-extended gastrin acts as an autocrine growth factor in a non-transformed cell line
36. Growth-promoting effects of glycine-extended progastrin
37. Autocrine stimulation of ARA-2J rat pancreatic cell growth by glycine-extended gastrin
38. Processing and proliferative effects of human progastrin in transgenic mice
39. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen
40. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM